We found that concomitant treatment with trametinib potently repressed basal and radiation-induced increase in pERK levels and expression of target genes of RAS-MAPK signaling in CRC cell lines (Figures 3E and 3F). Here, EIF2AK3 is linked to colorectal carcinoma.